Six experts resign from Trump HIV/AIDS panel

June 19, 2017

Six top health advisors have resigned from Donald Trump's advisory council on HIV/AIDS, complaining that the US president doesn't really care about combatting the illness.

In a letter published Friday in Newsweek, Scott Schoettes said the Trump administration has "no strategy" on AIDS and that he and his five colleagues will be more effective advocating for change from the outside.

Schoettes, counsel and HIV project director at Lambda Legal, resigned Tuesday from the Presidential Advisory Council on HIV/AIDS, along with Lucy Bradley-Springer, Gina Brown, Ulysses Burley III, Michelle Ogle and Grissel Granados.

The council can have up to 25 members.

"The Trump administration has no strategy to address the on-going HIV/AIDS epidemic, seeks zero input from experts to formulate HIV policy, and—most concerning—pushes legislation that will harm people living with HIV and halt or reverse important gains made in the fight against this disease," Schoettes wrote.

"If we do not ensure that US leadership at the executive and legislative levels are informed by experience and expertise, real people will be hurt and some will even die," he said.

"Because we do not believe the Trump administration is listening to—or cares—about the communities we serve as members of PACHA, we have decided it is time to step down."

PACHA, which was created in 1995, includes , researchers, , faith leavers, HIV advocates and people living with HIV. Its helps inform the National HIV/AIDS Strategy, which was last revised in 2015.

Schoettes noted that Trump failed to appoint a head of the White House Office of National AIDS Policy, a senior advisory position, and took down the Office of National AIDS Policy website the very day he took office—on January 20—and has yet to replace it.

He also stressed that changes Trump and his fellow Republicans in Congress are seeking to the sweeping care reform initiated by former president Barack Obama would be "extremely harmful" to people living with HIV or AIDS.

Schoettes cited data showing that only 40 percent of people living with HIV in the United States can access life-saving medications.

Explore further: National Archives to White House: Save all Trump tweets

Related Stories

National Archives to White House: Save all Trump tweets

April 3, 2017
The National Archives and Records Administration has told the White House to keep each of President Donald Trump's tweets, even those he deletes or corrects, and the White House has agreed.

Trump signs NASA bill, ponders sending Congress to space (Update 3)

March 21, 2017
President Donald Trump signed legislation Tuesday adding human exploration of Mars to NASA's mission. Could sending Congress into space be next?

The health consequences of Trump's global gag order

May 19, 2017
President Donald Trump recently signed an executive order that media reports say could obstruct nearly US$8.8 billion the U.S. spends annually to fight deadly diseases abroad. Here, Maureen Miller, a Columbia University Medical ...

Trump doesn't rule out 'amended' Obamacare: WSJ

November 11, 2016
US President-elect Donald Trump has said he will consider an "amended" version of Barack Obama's signature health care law—a sign of a shift in position after repeatedly vowing on the campaign trail that he would repeal ...

Recommended for you

Long-acting injectable implant shows promise for HIV treatment and prevention

October 9, 2018
A persistent challenge in HIV/AIDS treatment and prevention is medication adherence – getting patients to take their medication as required to get the best results.

Scientists develop rapid test for diagnosing tuberculosis in people with HIV

October 8, 2018
An international team that includes Rutgers scientists has made significant progress in developing a urine diagnostic test that can quickly, easily and inexpensively identify tuberculosis infection in people also infected ...

Researchers uncover new role of TIP60 protein in controlling tumour formation

October 8, 2018
Scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) have discovered a new molecular pathway that controls colorectal cancer development, and their exciting ...

Combination therapy targets latent reservoir of HIV

October 3, 2018
With more than 35 million people worldwide living with the virus and nearly 2 million new cases each year, the human immunodeficiency virus (HIV) remains a major global epidemic. Existing antiretroviral drugs do not cure ...

Anti-integrin therapy effect on intestinal immune system in HIV-infected patients

October 3, 2018
In a study published today in Science Translational Medicine, Mount Sinai researchers describe for the first time a mechanism that may shrink collections of immune cells in the gastrointestinal (GI) tract, called lymphoid ...

No 'reservoir': Detectable HIV-1 in treated human liver cells found to be inert

October 1, 2018
In a proof-of-principle study, researchers at Johns Hopkins report that a certain liver immune cell called a macrophage contains only defective or inert HIV-1 copies, and aren't likely to restart infection on their own in ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.